Have a personal or library account? Click to login

Therapeutic effect of umbilical cord mesenchymal stem cells on renal ischemia-reperfusion injury

Open Access
|Apr 2025

References

  1. P. O. Ludes, C. de Roquetaillade, B. G. Chousterman, J. Pottecher and A. Mebazaa, Role of damage-associated molecular patterns in septic acute kidney injury, from injury to recovery, Front. Immunol. 12 (2021) Article ID 606622 (11 pages); https://doi.org/10.3389/fimmu.2021.606622
  2. M. Tran, C. Parris and L. Wang, The role of PPP1R3G in promoting necroptosis in ischemia reper-fusion induced acute kidney injury, Physiology 39(S1) (2024) Article ID 796; https://doi.org/10.1152/physiol.2024.39.S1.796
  3. C. Tang, M. J. Livingston, R. Safirstein and Z. Dong, Cisplatin nephrotoxicity: New insights and therapeutic implications, Nat. Rev. Nephrol. 19(1) (2023) 53–72; https://doi.org/10.1038/s41581-022-00631-7
  4. A. S. Jannot, A. Burgun, E. Thervet and N. Pallet, The diagnosis-wide landscape of hospital-acquired AKI, Clin. J. Am. Soc. Nephrol. 12(6) (2017) 874–884; https://doi.org/10.2215/cjn.10981016
  5. S. M. Sancho-Martínez, J. M. López-Novoa and F. J. López-Hernández, Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury, Clin. Kidney J. 8(5) (2015) 548–559; https://doi.org/10.1093/ckj/sfv069
  6. Q. Huang, Y. Yang, T. Zhao, Q. Chen, M. Liu, S. Ji, Y. Zhu, Y. Yang, J. Zhang, H. Zhao, Y. Nan and K. Ai, Passively-targeted mitochondrial tungsten-based nanodots for efficient acute kidney injury treatment, Bioact. Mater. 21 (2023) 381–393; https://doi.org/10.1016/j.Bioact.mat.2022.08.022
  7. Q. Chen, Y. Nan, Y. Yang, Z. Xiao, M. Liu, J. Huang, Y. Xiang, X. Long, T. Zhao, X. Wang, Q. Huang and K. Ai, Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney, Bioact. Mater. 22 (2023) 141–167; https://doi.org/10.1016/j.Bioact.mat.2022.09.021
  8. X. Xie, X. Yang, J. Wu, S. Tang, L. Yang, X. Fei and M. Wang, Exosome from indoleAm.ine 2,3-dioxygenase-overexpressing bone marrow mesenchymal stem cells accelerates repair process of ischemia/reperfusion-induced acute kidney injury by regulating macrophages polarization, Stem Cell Res. Ther. 13(1) (2022) Article ID 367 (14 pages); https://doi.org/10.1186/s13287-022-03075-9
  9. J. Y. Cao, B. Wang, T. T. Tang, Y. Wen, Z. L. Li, S. T. Feng, M. Wu, D. Liu, D. Yin, K. L. Ma, R. N. Tang, Q. L. Wu, H. Y. Lan, L. L. Lv and B. C. Liu, Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury, Theranostics 11(11) (2021) 5248–5266; https://doi.org/10.7150/thno.54550
  10. M. Morigi and A. Benigni, Mesenchymal stem cells and kidney repair, Nephrol. Dial. Transplant. 28(4) (2013) 788–793; https://doi.org/10.1093/ndt/gfs556
  11. K. Iseri, M. Iyoda, H. Ohtaki, K. Matsumoto, Y. Wada, T. Suzuki, Y. Yamamoto, T. Saito, K. Hihara, S. Tachibana, K. Honda and T. Shibata, Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats, Am. J. Physiol. Renal Physiol. 310(11) (2016) F1182-91; https://doi.org/10.1152/ajprenal.00165.2016
  12. B. Sun, X. Luo, C. Yang, P. Liu, Y. Yang, X. Dong, Z. Yang, J. Xu, Y. Zhang and L. Li, Therapeutic effects of human urine-derived stem cells in a rat model of cisplatin-induced acute kidney injury in vivo and in vitro, Stem Cells Int. 2019(1) (2019) Article ID 8035076 (13 pages); https://doi.org/10.1155/2019/8035076
  13. Y. L. Si, Y. L. Zhao, H. J. Hao, X. B. Fu and W. D. Han, MSCs: Biological characteristics, Clinical applications and their outstanding concerns, Ageing Res. Rev. 10(1) (2011) 93–103; https://doi.org/10.1016/j.arr.2010.08.005
  14. N. D. Theise, S. Badve, R. Saxena, O. Henegariu, S. Sell, J. M. Crawford and D. S. Krause, Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation, Hepatology 31(1) (2000) 235–240; https://doi.org/10.1002/hep.510310135
  15. H. Huang, X. Liu, J. Wang, M. Suo, J. Zhang, T. Sun, W. Zhang and Z. Li, Umbilical cord mesenchymal stem cells for regenerative treatment of intervertebral disc degeneration, Front. Cell Dev. Biol. 11 (2023) Article ID 1215698 (11 pages); https://doi.org/10.3389/fcell.2023.1215698
  16. H. Ren, Y. Sang, F. Zhang, Z. Liu, N. Qi and Y. Chen, Comparative analysis of human mesenchymal stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy, Stem Cells Int. 2016 (2016) Article ID 3516574 (13 pages); https://doi.org/10.1155/2016/3516574
  17. C. Sávio-Silva, P. E. Soinski-Sousa, M. T. A. Balby-Rocha, Á. O. Lira and É. B. Rangel, Mesenchymal stem cell therapy in acute kidney injury (AKI): Review and perspectives, Rev. Assoc. Med. Bras. 66(Suppl 1) (2020) s45–s54; https://doi.org/10.1590/1806-9282.66.S1.45
  18. Q. Guo and J. Wang, Effect of combination of vitamin E and umbilical cord-derived mesenchymal stem cells on inflammation in mice with acute kidney injury, Immunopharmacol Immunotoxicol. 40(2) (2018) 168–172; https://doi.org/10.1080/08923973.2018.1424898
  19. Y. Yang, J. Gao, S. Wang, W. Wang, F. L. Zhu, X. Wang, S. Liang, Z. Feng, S. Lin, L. Zhang, X. Chen and G. Cai, Efficacy of umbilical cord mesenchymal stem cell transfusion for the treatment of severe AKI: A protocol for a randomised controlled trial, BMJ. Open 12(2) (2022) Article ID e047622 (7 pages); https://doi.org/10.1136/bmjopen-2020-047622
  20. H. Zhu, J. Wang, J. Miao, M. Shen, H. Wang, X. Huang, A. Ni, H. Wu, J. Chen and L. Xiao, SNORD3A regulates STING transcription to promote ferroptosis in acute kidney injury, Adv. Sci. 11(33) (2024) Article ID 2400305 (15 pages); https://doi.org/10.1002/advs.202400305
  21. F. Ren, J. Lin, M. Zhu, R. Ma, M. Zhang, W. Chen, G. Ma, H. Chen, R. He and W. Chen, Polysaccharides from Alpinia oxyphylla fruit prevent hyperuricemia by inhibiting uric acid synthesis, modulating intestinal flora and reducing renal inflammation, Int. Nat. J. Biol. Macromol. 278 (2024) Article ID 134782; https://doi.org/10.1016/j.ijbiomac.2024.134782
  22. J. Zhang, T. Wu, C. Li and J. Du, A glycopolymersome strategy for ‘drug-free’ treatment of diabetic nephropathy, J. Control. Release 372 (2024) 347–361; https://doi.org/10.1016/j.jconrel.2024.06.049
  23. Z. Deng, M. He, H. Hu, W. Zhang, Y. Zhang, Y. Ge, T. Ma, J. Wu, L. Li, M. Sun, S. An, J. Li, Q. Huang, S. Gong, J. Zhang, Z. Chen and Z. Zeng, Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation, Autophagy 20(1) (2024) 151–165; https://doi.org/10.1080/15548627.2023.2252265
  24. K. A. Mapuskar, C. F. Pulliam, A. Tomanek-Chalkley, P. Rastogi, H. Wen, S. Dayal, B. R. Griffin, D. Zepeda-Orozco, A. L. Sindler, C. M. Anderson, R. Beardsley, E. P. Kennedy, D. R. Spitz and B. G. Allen. The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury, Redox Biol. 70 (2024) Article ID 103022 (11 pages); https://doi.org/10.1016/j.redox.2023.103022
  25. Q. Wei, X. Xiao, P. Fogle and Z. Dong, Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion, PLoS One 9(9) (2014) Article ID e106647; https://doi.org/10.1371/journal.pone.0106647
  26. J. V. Bonventre and L. Yang, Cellular pathophysiology of ischemic acute kidney injury, J. Clin. Invest. 121(11) (2011) 4210–4221; https://doi.org/10.1172/jci45161
  27. S. Qin, B. Wu, T. Gong, Z. R. Zhang and Y. Fu, Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury, J. Control. Release 349 (2022) 401–412; https://doi.org/10.1016/j.jconrel.2022.07.013
  28. X. Fu, G. Liu, A. Halim, Y. Ju, Q. Luo and A. G. Song, Mesenchymal stem cell migration and tissue repair, Cells 8(8) (2019) Article ID 784; https://doi.org/10.3390/cells8080784
  29. A. Kapisiz, C. Kaya, S. Eryilmaz, R. Karabulut, Z. Turkyilmaz, M. A. Inan, O. Gulbahar and K. Sonmez, Protective effects of lupeol in rats with renal ischemia-reperfusion injury, Exp. Ther. Med. 28(2) (2024) Article ID 313 (10 pages); https://doi.org/10.3892/etm.2024.12602
  30. M. A. Daemen, B. de Vries and W. A. Buurman, Apoptosis and inflammation in renal reperfusion injury, Transplantation 73(11) (2002) 1693–1700; https://doi.org/10.1097/00007890-200206150-00001
  31. J. Wang, H. Zhu, J. Miao, W. Lin and F. Han, Bilateral renal ischemia-reperfusion model for acute kidney injury in mice, J. Vis. Exp. 204 (2024) e65838; https://doi.org/10.3791/65838
  32. A. Pefanis, F. L. Ierino, J. M. Murphy and P. J. Cowan, Regulated necrosis in kidney ischemia--reperfusion injury, Kidney Int. 96(2) (2019) 291–301; https://doi.org/10.1016/j.kint.2019.02.009
  33. A. Dos Anjos Cassado, F4/80 as a major macrophage marker: The case of the peritoneum and spleen, Results Probl. Cell Differ. 62 (2017) 161–179; https://doi.org/10.1007/978-3-319-54090-0_7
  34. T. J. Fleming, M. L. Fleming and T. R. Malek, Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family, J. Immunol. 151(5) (1993) 2399–2408; https://doi.org/10.4049/jimmunol.151.5.2399
  35. F. T. Sari, F. Sari, F. Sari, N. Arfian and D. Sari, Effect of kidney ischemia/reperfusion injury on proliferation, apoptosis, and cellular senescence in acute kidney injury in mice, Med. J. Malaysia 75(Suppl 1) (2020) 20–23.
  36. S. Watanabe, T. Matsushita, K. Nishida, K. Nagai, Y. Hoshino, T. Matsumoto and R. Kuroda, Knee osteotomy decreases joint inflammation based on synovial histology and synovial fluid analysis, Arthroscopy 40(3) (2024) 830–843; https://doi.org/10.1016/j.arthro.2023.07.008
  37. Y. Wang, J. Fang, B. Liu, C. Shao and Y. Shi, Reciprocal regulation of mesenchymal stem cells and immune responses, Cell Stem Cell 29(11) (2022) 1515–1530; https://doi.org/10.1016/j.stem.2022.10.001
  38. G. Ren, L. Zhang, X. Zhao, G. Xu, Y. Zhang, A. I. Roberts, R. C. Zhao and Y. Shi, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide, Cell Stem Cell 2(2) (2008) 141–150; https://doi.org/10.1016/j.stem.2007.11.014
  39. S. S. Kuppa, H. K. Kim, J. Y. Kang, S. C. Lee and J. K. Seon, Role of mesenchymal stem cells and their paracrine mediators in macrophage polarization: An approach to reduce inflammation in osteoarthritis, Int. J. Mol. Sci. 23(21) (2022) Article ID 13016 (31 pages); https://doi.org/10.3390/ijms232113016
  40. R. Margiana, A. Markov, A. O. Zekiy, M. U. Hamza, K. A. Al-Dabbagh, S. H. Al-Zubaidi, N. M. Hameed, I. Ahmad, R. Sivaraman, H. H. Kzar, M. E. Al-Gazally, Y. F. Mustafa and H. Siahmansouri, Clinical application of mesenchymal stem cell in regenerative medicine: A narrative review, Stem Cell Res. Ther. 13(1) (2022) Article ID 366 (22 pages); https://doi.org/10.1186/s13287-022-03054-0
  41. H. K. Chae, N. Suh, M. J. Jang, Y. S. Kim, B. H. Kim, J. Aum, H. C. Shin, D. You, B. Hong, H. K. Park and C. S. Kim, Efficacy and safety of human bone marrow-derived mesenchymal stem cells according to injection route and dose in a chronic kidney disease rat model, Int. J. Stem Cells 16(1) (2023) 66–77; https://doi.org/10.15283/ijsc21146
  42. D. K. de Vries, A. F. Schaapherder and M. E. Reinders, Mesenchymal stromal cells in renal ischemia/reperfusion injury, Front. Immunol. 3 (2012) Article ID 162 (8 pages); https://doi.org/10.3389/fimmu.2012.00162
  43. F. Tögel, Z. Hu, K. Weiss, J. Isaac, C. Lange and C. Westenfelder, Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms, Am. J. Physiol. Renal Physiol. 289(1) (2005) F31-42; https://doi.org/10.1152/ajprenal.00007.2005
  44. B. Bi, R. Schmitt, M. Israilova, H. Nishio and L. G. Cantley, Stromal cells protect against acute tubular injury via an endocrine effect, J. Am. Soc. Nephrol. 18(9) (2007) 2486–2496; https://doi.org/10.1681/asn.2007020140
  45. M. Barakat, A. M. Hussein, M. F. Salama, A. Awadalla, N. Barakat, M. Serria, M. El-Shafey, M. El-Sherbiny and M. A. El Adl, Possible underlying mechanisms for the renoprotective effect of retinoic acid-pretreated Wharton’s Jelly mesenchymal stem cells against renal ischemia/reperfusion injury, Cells 11(13) (2022); Article ID 1997 (21 pages); https://doi.org/10.3390/cells11131997
  46. Y. S. Kim, J. Aum, B. H. Kim, M. J. Jang, J. Suh, N. Suh and D. You, Therapeutic effect of three--dimensional cultured adipose-derived stem cell-conditioned medium in renal ischemia-reper-fusion injury, Int. J. Stem Cells 16(2) (2023) 168–179; https://doi.org/10.15283/ijsc22137
DOI: https://doi.org/10.2478/acph-2025-0006 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 103 - 118
Accepted on: Mar 3, 2025
Published on: Apr 10, 2025
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2025 Liang Xiao, Chengyu Huang, Shanghua Xiao, Lingfeng Xie, Xueyan Zhang, Fucheng Xiao, Huajia Cai, Shuibo Yang, Shengqing Wu, Shoukang Qu, Jia Liu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.